Social influences on clinical outcomes of patients with ovarian cancer

Journal of Clinical Oncology

Volumn 30, Issue 23, 2012, Pages 2885-2890

  Lutgendorf, Susan K ^a,b   De Geest, Koen ^a   Bender, David ^a   Ahmed, Amina ^a   Goodheart, Michael J ^a   Dahmoush, Laila ^a   Zimmerman, M Bridget ^a   Penedo, Frank J ^c   Lucci III, Joseph A ^c   Ganjei Azar, Parvin ^c   Thaker, Premal H ^d   Mendez, Luis ^e   Lubaroff, David M ^a,b   Slavich, George M ^f   Cole, Steven W ^g   Sood, Anil K ^h  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EMOTIONAL ATTACHMENT; FEMALE; HISTOPATHOLOGY; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOCIAL ISOLATION; SOCIAL SUPPORT;

AGED; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OUTCOME ASSESSMENT (HEALTH CARE); OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SOCIAL SUPPORT;

EID: 84865073284     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.4411     Document Type: Article

References (59)

1. American Cancer Society: Cancer Facts & Figures 2010. Atlanta, GA, American Cancer Society, 2010
2. Lutgendorf SK, Sood AK, Antoni MH: Host factors and cancer progression: Biobehavioral signaling pathways and interventions. J Clin Oncol 28:4094-4099, 2010
3. Helgeson VS, Cohen S: Social support and adjustment to cancer: Reconciling descriptive, correlational, and intervention research. Health Psychol 15:135-148, 1996
4. Carpenter KM, Fowler JM, Maxwell GL, et al: Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med 39:79-90, 2010
5. Cohen S, Wills TA: Stress, social support, and the buffering hypothesis. Psychol Bull 98:310-357, 1985
6. Cohen S, Underwood LG, Gottlieb BH: Social Support Measurement and Intervention: A Guide for Health and Social Scientists. New York, NY, Oxford University Press, 2000
7. Cutrona C, Russell D: Type of social support and specific stress: Toward a theory of optimal matching, in Sarason BR, Sarason IG, Pierce GR (eds): Social Support: An Interactional View. New York, NY, Wiley, 1990
8. House JS, Landis KR, Umberson D: Social relationships and health. Science 241:540-545, 1988
9. Nausheen B, Gidron Y, Peveler R, et al: Social support and cancer progression: A systematic review. J Psychosom Res 67:403-415, 2009
10. Pinquart M, Duberstein PR: Associations of social networks with cancer mortality: A metaanalysis. Crit Rev Oncol Hematol 75:122-137, 2010
11. Sprehn GC, Chambers JE, Saykin AJ, et al: Decreased cancer survival in individuals separated at time of diagnosis: Critical period for cancer pathophysiology? Cancer 115:5108-5116, 2009
12. Kroenke CH, Kubzansky LD, Schernhammer ES, et al: Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 24:1105-1111, 2006
13. Lehto US, Ojanen M, Dyba T, et al: Baseline psychosocial predictors of survival in localised breast cancer. Br J Cancer 94:1245-1252, 2006
14. Villingshøj M, Ross L, Thomsen BL, et al: Does marital status and altered contact with the social network predict colorectal cancer survival? Eur J Cancer 42:3022-3027, 2006
15. Lutgendorf SK, Sood AK, Anderson B, et al: Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 23:7105-7113, 2005
16. Lutgendorf SK, De Geest K, Dahmoush L, et al: Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 25:250-255, 2010
17. Lutgendorf SK, De Geest K, Sung CY, et al: Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav Immun 23:176-183, 2009
18. Lutgendorf SK, Lamkin DM, Jennings NB, et al: Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clin Cancer Res 14:6839-6846, 2008
19. Lutgendorf SK, Johnsen EL, Cooper B, et al: Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 95:808-815, 2002
20. Costanzo ES, Lutgendorf SK, Sood AK, et al: Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 104:305-313, 2005
21. House J, Kahn R, McLeod J, et al: Measures and concepts of social support, in Cohen S, Syme SL (eds): Social Support and Health. New York, NY, Academic Press, 1985, pp 83-108
22. Cutrona CE: Social support and stress in the transition to parenthood. J Abnorm Psychol 93:378- 390, 1984
23. Cutrona CE, Russell DW: The provisions of social relationships and adaptation to stress, in Perlman D, Jones WH (eds): Advances in Personal Relationships, Vol. 1. Greenwich, CT, JAI Press, 1987, pp 37-67
24. Russell D, Cutrona CE, Rose J, et al: Social and emotional loneliness: An examination of Weiss's typology of loneliness. J Pers Soc Psychol 46:1313-1321, 1984
25. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for DSM-IV Axis I Disorders-Nonpatient Edition (SCID-I/NP, version 2.0-4/97 revision). New York, NY, New York State Psychiatric Institute, 1997
26. Williams JB, Gibbon M, First MB, et al: The Structured Clinical Interview for DSM-III-R (SCID): II. Multisite test-retest reliability. Arch Gen Psychiatry 49:630-636, 1992
27. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
28. Singer JD, Willett JB: Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, NY, Oxford University Press, 2003
29. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
30. Ell K, Nishimoto R, Mediansky L, et al: Social relations, social support and survival among patients with cancer. J Psychosom Res 36:531-541, 1992
31. Maunsell E, Brisson J, Deschênes L: Social support and survival among women with breast cancer. Cancer 76:631-637, 1995
32. Burns CM, Craft PS, Roder DM: Does emotional support influence survival? Findings from a longitudinal study of patients with advanced cancer. Support Care Cancer 13:295-302, 2005
33. Marshall JR, Funch DP: Social environment and breast cancer: A cohort analysis of patient survival. Cancer 52:1546-1550, 1983
34. Waxler-Morrison N, Hislop TG, Mears B, et al: Effects of social relationships on survival for women with breast cancer: A prospective study. Soc Sci Med 33:177-183, 1991
35. Hislop TG, Waxler NE, Coldman AJ, et al: The prognostic significance of psychosocial factors in women with breast cancer. J Chronic Dis 40:729-735, 1987
36. Pinquart M, Höffken K, Silbereisen RK, et al: Social support and survival in patients with acute myeloid leukaemia. Support Care Cancer 15:81-87, 2007
37. Thaker PH, Han LY, Kamat AA, et al: Chronic stress promotes tumor growth and metastasis in a mouse model of ovarian carcinoma. Nat Med 12: 939-944, 2006
38. Landen CN Jr, Lin YG, Armaiz Pena GN, et al: Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 67:10389-10396, 2007
39. Sood AK, Bhatty R, Kamat AA, et al: Stress hormone mediated invasion of ovarian cancer cells. Clin Cancer Res 12:369-375, 2006
40. Sood AK, Armaiz-Pena GN, Halder J, et al: Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest 120:1515-1523, 2010
41. Sloan EK, Priceman SJ, Cox BF, et al: The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 70:7042-7052, 2010
42. Yang EV, Donovan EL, Benson DM, et al: VEGF is differentially regulated in multiple myelomaderived cell lines by norepinephrine. Brain Behav Immun 22:318-323, 2008
43. Yang EV, Kim SJ, Donovan EL, et al: Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stressrelated enhancement of tumor progression. Brain Behav Immun 23:267-275, 2009
44. Yang EV, Sood AK, Chen M, et al: Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66:10357-10364, 2006
45. Miller GE, Chen E, Sze J, et al: A functional genomic fingerprint of chronic stress in humans: Blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry 64:266-272, 2008
46. Irwin MR, Wang M, Campomayor CO, et al: Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166:1756-1762, 2006
47. Cole SW, Hawkley LC, Arevalo JM, et al: Social regulation of gene expression in human leukocytes. Genome Biol 8:R189, 2007
48. Zhao XY, Malloy PJ, Krishnan AV, et al: Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 6:703-706, 2000
49. Simon WE, Albrecht M, Trams G, et al: In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst 73:313-321, 1984
50. Moran TJ, Gray S, Mikosz CA, et al: The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res 60:867-872, 2000
51. Antonova L, Mueller CR: Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: A possible molecular link between stress and breast cancer. Genes Chromosomes Cancer 47:341-352, 2008
52. Herr I, Ucur E, Herzer K, et al: Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res 63:3112-3120, 2003
53. Wu W, Chaudhuri S, Brickley DR: Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64:1757-1764, 2004
54. Pang D, Kocherginsky M, Krausz T, et al: Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis. Cancer Biol Ther 5:933-940, 2006
55. Moreno-Smith M, Lu C, Shahzad MM, et al: Dopamine blocks stress-mediated ovarian carcinoma growth. Clin Cancer Res 17:3649-3659, 2011
56. Sastry KS, Karpova Y, Prokopovich S, et al: Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem 282:14094-14100, 2007
57. Sastry KS, Smith AJ, Karpova Y, et al: Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. J Biol Chem 281:20891-20901, 2006
58. Taylor SE, Klein LC, Lewis BP, et al: Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight. Psychol Rev 107:411-429, 2000
59. Morita T, Shibata K, Kikkawa F, et al: Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo. Int J Cancer 109:525-532, 2004